ResearcherVan Andel InstituteNo recent work listed
Daniel Barnett
Matched on ORCID iD 0000-0003-3512-3329; OpenAlex author ID A5009767800. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper
Papers 3
- Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. Co-author DOI 10.1158/1078-0432.ccr-20-2475↗
- The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. Co-author DOI 10.1158/1078-0432.ccr-18-3310↗
- The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. Co-author DOI 10.1038/s41598-017-04164-z↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Randall E. Brand · 3 shared papers, 2017–2021 · strength 0.25
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Paper The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. DOI 10.1038/s41598-017-04164-z↗
- Richard R. Drake · 3 shared papers, 2017–2021 · strength 0.25
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Paper The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. DOI 10.1038/s41598-017-04164-z↗
- Brian B. Haab · 3 shared papers, 2017–2021 · strength 0.25
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Paper The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. DOI 10.1038/s41598-017-04164-z↗
- Aatur Dilip Singhi · 3 shared papers, 2017–2021 · strength 0.25
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Paper The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. DOI 10.1038/s41598-017-04164-z↗
- Ying Huang · 3 shared papers, 2017–2021 · strength 0.25
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Paper The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. DOI 10.1038/s41598-017-04164-z↗
- Ben Staal · 2 shared papers, 2019–2021 · strength 0.18
- ChongFeng Gao · 2 shared papers, 2019–2021 · strength 0.18
- Ying Liu · 2 shared papers, 2017–2021 · strength 0.17
- Peter J. Allen · 1 shared paper, 2021 · strength 0.10
- Amer H. Zureikat · 1 shared paper, 2021 · strength 0.10
- Luke Wisniewski · 1 shared paper, 2021 · strength 0.10
- Mohammed Aldakkak · 1 shared paper, 2021 · strength 0.10
- Douglas B. Evans · 1 shared paper, 2021 · strength 0.10
- Susan Tsai · 1 shared paper, 2021 · strength 0.10
- David Arthur Tuveson · 1 shared paper, 2021 · strength 0.10
- Anirban Maitra · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.